ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Black Tea Is Great for Your Gut

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

 
Print Page
Email Article

Previous immunoglobulin therapy appears to cut Alzheimer’s risk - national treatment trial under way

  [ 27 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 25, 2009


“The current Alzheimer’s drugs on the market treat the symptoms of the disease. Immunization could treat the underlying cause.”

IVIg treatments - the addition of good antibodies into the blood stream - may hold promise for lowering the risk of Alzheimer’s disease and other similar brain disorders, according to research published in the July 21 issue of Neurology,(1) the medical journal of the American Academy of Neurology.

“In our study, we looked at the association of the use of intravenous immunoglobulin (IVIg) with the occurrence of Alzheimer’s disease. IVIg has been used safely for more than 20 years to treat other diseases but is thought to have an indirect effect on Alzheimer’s disease by targeting beta-amyloid, or plaques in the brain,” said Howard Fillit, MD, with the Mount Sinai School of Medicine in New York.

For the study, researchers analyzed the medical records of 847 people given at least one treatment of IVIg over four years and 84,700 who were not given IVIg treatment. Participants were treated for immune deficiencies, leukemia or other types of cancer, anemia and other diseases. The records were pulled from a database of 20 million patients age 65 or older developed by SDI Health. Scientists made sure the groups were similar in their risk factors for Alzheimer’s disease.

The study found that people who received IVIg for other conditions had a 42 percent lower risk of developing Alzheimer’s disease over four years compared to those who did not receive IVIg.

Only 2.8 percent of those treated with IVIg developed Alzheimer’s disease compared with 4.8 percent of those not treated with immune-based therapy.

“Our study provides evidence that previous IVIg treatments may protect against Alzheimer’s disease,” said Fillit. “The current Alzheimer’s drugs on the market treat the symptoms of the disease. Immunization could treat the underlying cause.”

33-center treatment trial now recruiting

“These findings do not constitute an endorsement of IVIg treatment for Alzheimer’s disease. A large scale clinical trial is underway to determine whether IVIg could be an effective treatment for Alzheimer’s,” researchers said.

[Note: For information about this trial, which is recruiting at 33 centers across the U.S., see ClinicalTrials.gov - “A Phase 3 study evaluating safety and effectiveness of IGIV for the treatment of mild to moderate Alzheimer’s disease.”

The study was supported by Baxter International Inc., a manufacturer of IVIg.
___
1. Article: “IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders”

Source: American Academy of Neurology news release, Jul 20, 2009




Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Optimized Curcumin Longvida® Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Improve Cardiovascular and Metabolic Health with Omega-7 Improve Cardiovascular and Metabolic Health with Omega-7
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map